Gene expression profile of activated microglia under conditions associated with dopamine neuronal damage
- 29 December 2005
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 20 (3) , 515-517
- https://doi.org/10.1096/fj.05-4873fje
Abstract
SPECIFIC AIMSMicroglia are the primary resident antigen-presenting cells within the central nervous system (CNS) and are thought to serve immune-like functions in protecting the brain against injury and invading pathogens. By mechanisms not yet fully understood, microglia can become activated in the early phases of neurodegenerative conditions and in response to certain neurotoxic drugs of abuse. Once activated, microglia produce and secrete reactive species, cytokines, and chemokines known to cause or enhance damage to neurons. A better understanding of the gene expression response of microglia to activation would provide important mechanistic information on how these cells participate in the process of neuronal damage. The specific aims of this study were to 1) elaborate the transcriptome of resting microglia; 2) activate cultured microglial cells with lipopolysaccharide (LPS), the neurotoxic HIV protein TAT, or dopamine (DA) quinone (DAQ), each of which has been linked causally to damage of the DA neur...Keywords
This publication has 52 references indexed in Scilit:
- MPP+‐induced COX‐2 activation and subsequent dopaminergic neurodegenerationThe FASEB Journal, 2005
- Association with Class IIa Histone Deacetylases Upregulates the Sumoylation of MEF2 Transcription FactorsMolecular and Cellular Biology, 2005
- Microglial activation precedes dopamine terminal pathology in methamphetamine-induced neurotoxicityExperimental Neurology, 2004
- Synergistic dopaminergic neurotoxicity of MPTP and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson's diseaseThe FASEB Journal, 2003
- Productive HIV-2 infection in the brain is restricted to macrophages/microgliaAIDS, 2003
- Role of Microglia in Inflammation-Mediated Neurodegenerative Diseases: Mechanisms and Strategies for Therapeutic InterventionThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Microglia as neuroprotective, immunocompetent cells of the CNSGlia, 2002
- Parkinsonism in HIV dementiaJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2002
- Antibodies from patients with Parkinson's disease react with protein modified by dopamine oxidationJournal of Neuroscience Research, 1998
- Microglia: a sensor for pathological events in the CNSTrends in Neurosciences, 1996